Activist hedge fund Starboard Value LP on Friday abandoned a campaign to convince Bristol-Myers Squibb Co shareholders to vote down the drugmaker’s proposed $74 billion takeover of biotech Celgene Corp after the two leading proxy advisory firms backed the deal.
Source:: Reuters – Business News
